These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 6370760)
1. Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission. Ludvigsson J Diabetologia; 1984 Feb; 26(2):138-41. PubMed ID: 6370760 [TBL] [Abstract][Full Text] [Related]
2. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up. Dorchy H; Duchateau J; Bosson D; D'Hooge D Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052 [TBL] [Abstract][Full Text] [Related]
3. Development of insulin antibodies, metabolic control and B-cell function in newly diagnosed insulin dependent diabetic children treated with monocomponent human insulin or monocomponent porcine insulin. Marshall MO; Heding LG; Villumsen J; Akerblom HK; Baevre H; Dahlquist G; Kjaergaard JJ; Knip M; Lindgren F; Ludvigsson J Diabetes Res; 1988 Dec; 9(4):169-75. PubMed ID: 3073903 [TBL] [Abstract][Full Text] [Related]
4. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins. Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441 [TBL] [Abstract][Full Text] [Related]
5. [HLA typing and insulin antibody production in insulin-dependent diabetics]. Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038 [TBL] [Abstract][Full Text] [Related]
7. HLA-types, C-peptide and insulin antibodies in juvenile diabetes. Ludvigsson J; Säfwenberg J; Heding LG Diabetologia; 1977 Jan; 13(1):13-7. PubMed ID: 838199 [TBL] [Abstract][Full Text] [Related]
8. C-peptide in children with juvenile diabetes. A preliminary report. Ludvigsson J; Heding LG Diabetologia; 1976 Dec; 12(6):627-30. PubMed ID: 1001852 [TBL] [Abstract][Full Text] [Related]
9. Abnormal proinsulin/C-peptide ratio in juvenile diabetes. Ludvigsson J; Heding L Acta Diabetol Lat; 1982; 19(4):351-8. PubMed ID: 6758459 [TBL] [Abstract][Full Text] [Related]
10. [Serum levels of insulin-binding antibodies in diabetic children treated with monocomponent insulin]. Symonides-Lawecka A; Ludwiczak H; Rogala H; Lawecki J; Czyzyk A Pol Tyg Lek; 1974 Apr; 29(16):641-3. PubMed ID: 4827230 [No Abstract] [Full Text] [Related]
11. Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects. Larkins RG; Zajac J; Saunders R; Read A; Hopper JL Aust N Z J Med; 1986 Apr; 16(2):206-10. PubMed ID: 3530226 [TBL] [Abstract][Full Text] [Related]
12. Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement. McEvoy RC; Witt ME; Ginsberg-Fellner F; Rubinstein P Diabetes; 1986 Jun; 35(6):634-41. PubMed ID: 3519320 [TBL] [Abstract][Full Text] [Related]
13. Insulin-binding antibodies in serum of diabetic children treated with monocomponent insulin. Symonides-Lawecka A; Ludwiczak H; Rogala H; Lawecki J; Czyzyk A Acta Diabetol Lat; 1974; 11(2):165-70. PubMed ID: 4432728 [No Abstract] [Full Text] [Related]
14. Normalization of complement activation and consumption in diabetic children and adolescents after switch-over from porcine to semisynthetic human insulin. Dorchy H; Duchateau J; D'Hooge D Diabete Metab; 1988; 14(4):415-21. PubMed ID: 3066649 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of insulin antibodies in diabetic patients with primary insulin-dependence (type I) and secondary insulin-dependence (type II). Ionescu-Tîrgovişte C; Mirodon Z; Cheţa D; Sântu E; Simionescu M; Nicolau A; Mincu I Med Interne; 1989; 27(4):303-11. PubMed ID: 2694321 [TBL] [Abstract][Full Text] [Related]
16. [Monocomponent insulins in the treatment of juvenile diabetes]. Kopecký A; Vavrinec J; Kimlová I; Pospísilová D Cesk Pediatr; 1984 Apr; 39(4):223-5. PubMed ID: 6375877 [No Abstract] [Full Text] [Related]
17. Insulin autoantibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes--a poor predictor of clinical course and antibody response to exogenous insulin. Karjalainen J; Knip M; Mustonen A; Akerblom HK Diabetologia; 1988 Mar; 31(3):129-33. PubMed ID: 3286339 [TBL] [Abstract][Full Text] [Related]
18. Insulin antibodies in diabetic children before treatment: a marker for islet B-cell destruction? De Beaufort CE; Binder C; Bruining GJ; Den Boer NC; Van Strik R Diabet Med; 1988; 5(5):441-3. PubMed ID: 2970916 [TBL] [Abstract][Full Text] [Related]
19. Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes. Knip M; Ilonen J; Mustonen A; Akerblom HK Diabetologia; 1986 Jun; 29(6):347-51. PubMed ID: 3527834 [TBL] [Abstract][Full Text] [Related]
20. Antibody formation and insulin requirements in diabetic children during treatment with purified commercial pork insulins. Weber B; Tech J; Schmidt H; Oberdisse U Eur J Pediatr; 1978 Jun; 128(2):89-102. PubMed ID: 566669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]